Siemens Healthineers company profile
Company profile
Siemens Healthineers has 74,600 employees and is headquartered in Forchheim, Germany.
Imaging, the first of the four reporting segments, covers MRI and CT scanners, X-ray, molecular imaging and ultrasound systems, together with software for reading diagnostic images. The other segments address laboratory and point-of-care testing, cancer treatment technologies and clinical services from Varian, and image-guided minimally invasive procedures in cardiology, neurology and oncology. Customers are healthcare providers in Germany, the United States, the rest of Europe, the Middle East, Africa, the Americas, Asia Pacific, Japan and China.
In the fiscal year ended 30 September 2026, revenue reached 23.6 billion euros, up 1.1% from the previous year, and net income was 2.2 billion euros. The company employs 74,600 people and is headquartered in Forchheim, Germany, where it was founded in 1896. It has strategic partnerships with IFS and Novo.
Company facts
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Germany
- Headquarters
- Siemensstr. 3, 91301, Forchheim
- Employees
- 74,600
- Chief executive
- Bernhard Montag
- Founded
- 1896
- Fiscal year
- October - September
- Listing
- SHL · Xetra
- Indices
- DAX
- Currency
- EUR
- ISIN
- DE000SHL1006
- Website
- siemens-healthineers.com
Siemens Healthineers and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Siemens HealthineersSHL | Germany | $54.12B | 74,600 | 13.5% | 22.3 |
| Koninklijke PhilipsPHIA | Netherlands | $29.59B | 63,909 | 8.8% | 67.2 |
| Sonova HoldingSOON | Switzerland | $20.44B | 18,837 | 20.6% | 28.6 |
| Smith & NephewSN. | United Kingdom | $12.99B | 17,000 | 14.2% | 21.4 |
| DemantDEMANT | Denmark | $10.86B | 26,616 | 17.2% | 30.5 |
| GetingeGETI.B | Sweden | $7.47B | 11,847 | 14.3% | 26.8 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
